摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(4-biphenyl)methylene]-3-oxobutanoic acid ethyl ester | 910097-43-7

中文名称
——
中文别名
——
英文名称
2-[(4-biphenyl)methylene]-3-oxobutanoic acid ethyl ester
英文别名
Ethyl 3-oxo-2-[(4-phenylphenyl)methylidene]butanoate
2-[(4-biphenyl)methylene]-3-oxobutanoic acid ethyl ester化学式
CAS
910097-43-7
化学式
C19H18O3
mdl
——
分子量
294.35
InChiKey
IRVBKDPZPMVYTR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    22
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-[(4-biphenyl)methylene]-3-oxobutanoic acid ethyl ester吡啶盐酸羟胺三乙胺 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 6.17h, 生成 (2Z,3E)-ethyl 2-(biphenyl-4-ylmethylene)-3-(4-(trifluoromethyl)benzoyloxyimino)butanoate
    参考文献:
    名称:
    酰基肟的可见光促进亚甲基基自由基形成:吡啶,喹啉和菲啶的统一方法
    摘要:
    已经建立了涉及可见光诱导的亚胺基自由基形成的统一策略,用于从酰基肟中构建吡啶,喹啉和菲啶。用FAC - [的Ir(ppy)3 ]作为催化剂photoredox,酰基肟通过1e中转化-还原成亚氨基自由基中间体,然后行分子内均裂芳族取代(HAS),得到含有N-芳烃其中。这些反应在室温下以宽范围的底物以高收率进行。这种可见光诱导的亚胺基自由基形成策略已成功地应用于五步精简合成苯并[ c ]菲啶生物碱。
    DOI:
    10.1002/anie.201411342
  • 作为产物:
    参考文献:
    名称:
    酰基肟的可见光促进亚甲基基自由基形成:吡啶,喹啉和菲啶的统一方法
    摘要:
    已经建立了涉及可见光诱导的亚胺基自由基形成的统一策略,用于从酰基肟中构建吡啶,喹啉和菲啶。用FAC - [的Ir(ppy)3 ]作为催化剂photoredox,酰基肟通过1e中转化-还原成亚氨基自由基中间体,然后行分子内均裂芳族取代(HAS),得到含有N-芳烃其中。这些反应在室温下以宽范围的底物以高收率进行。这种可见光诱导的亚胺基自由基形成策略已成功地应用于五步精简合成苯并[ c ]菲啶生物碱。
    DOI:
    10.1002/anie.201411342
点击查看最新优质反应信息

文献信息

  • Tacripyrines, the First Tacrine−Dihydropyridine Hybrids, as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease
    作者:José Marco-Contelles、Rafael León、Cristóbal de los Ríos、Abdelouahid Samadi、Manuela Bartolini、Vincenza Andrisano、Oscar Huertas、Xavier Barril、F. Javier Luque、María I. Rodríguez-Franco、Beatriz López、Manuela G. López、Antonio G. García、María do Carmo Carreiras、Mercedes Villarroya
    DOI:10.1021/jm801292b
    日期:2009.5.14
    Tacripyrines (1-14) have been designed by combining an ACNE inhibitor (tacrine) with a calcium antagonist such as nimodipine and are targeted to develop a multitarget therapeutic strategy to confront AD. Tacripyrines are selective and potent ACNE inhibitors in the nanomolar range. The mixed type inhibition of hAChE activity of compound 11 (IC50 105 +/- 15 nM) is associated to a 30.7 +/- 8.6% inhibition of the proaggregating action of ACNE on the A beta and a moderate inhibition of A beta self-aggregation (34.9 +/- 5.4%). Molecular modeling indicates that binding of compound 11 to the ACNE PAS mainly involves the (R)-11 enantiomer, which also agrees with the noncompetitive inhibition mechanism exhibited by p-methoxytacripyrine 11. Tacripyrines are neuroprotective agents, show moderate Ca2+ channel blocking effect, and cross the blood-brain barrier, emerging as lead candidates for treating AD.
  • Synthesis of 6-amino-1,4-dihydropyridines that prevent calcium overload and neuronal death
    作者:Rafael León、Cristóbal de los Ríos、José Marco-Contelles、Manuela G. López、Antonio G. García、Mercedes Villarroya
    DOI:10.1016/j.ejmech.2007.06.001
    日期:2008.3
    The synthesis and pharmacology of 6-amino-1,4-dihydropyridines, such as ethyl 6-amino-4-aryl-5-cyano-1,4-dihydro-2-methyl-3-pyridinecarboxylic acids (3-16) and 2-amino-4-aryl-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinenitriles (17-21) are described. Compounds 18 and 21, at the concentration of 0.3 mu M, proved to be the best blockers of the [Ca2+] overload induced by depolarization with high [K+] of SH-SY5Y neuroblastoma cells, with values of 63.8% and 50.4%, respectively. Most of the compounds induced a remarkable neuroprotective effect against toxicity caused by high [K+]-elicited [Ca2+] overload, and against H2O2-generated free radicals, in SH-SY5Y cells. (c) 2007 Elsevier Masson SAS. All rights reserved.
  • Visible-Light-Promoted Iminyl-Radical Formation from Acyl Oximes: A Unified Approach to Pyridines, Quinolines, and Phenanthridines
    作者:Heng Jiang、Xiaode An、Kun Tong、Tianyi Zheng、Yan Zhang、Shouyun Yu
    DOI:10.1002/anie.201411342
    日期:2015.3.23
    iminyl‐radical formation has been established for the construction of pyridines, quinolines, and phenanthridines from acyl oximes. With fac‐[Ir(ppy)3] as a photoredox catalyst, the acyl oximes were converted by 1 e− reduction into iminyl radical intermediates, which then underwent intramolecular homolytic aromatic substitution (HAS) to give the N‐containing arenes. These reactions proceeded with a broad
    已经建立了涉及可见光诱导的亚胺基自由基形成的统一策略,用于从酰基肟中构建吡啶,喹啉和菲啶。用FAC - [的Ir(ppy)3 ]作为催化剂photoredox,酰基肟通过1e中转化-还原成亚氨基自由基中间体,然后行分子内均裂芳族取代(HAS),得到含有N-芳烃其中。这些反应在室温下以宽范围的底物以高收率进行。这种可见光诱导的亚胺基自由基形成策略已成功地应用于五步精简合成苯并[ c ]菲啶生物碱。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐